Ticker Details
Rein Therapeutics, Inc. Common Stock
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$88.11M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 4.62%
Avg Daily Range (30 D):	$0.06 | 4.43%
Avg Daily Range (90 D):	$0.06 | 4.44%

Institutional Daily Volume
Avg Daily Volume:	.09M
Avg Daily Volume (30 D):	.97M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	215
Avg Trade Size (Sh.) (30 D):	339
Avg Trade Size (Sh.) (90 D):	314

Institutional Trades
Total Institutional Trades:	3
Avg Institutional Trade:	$.89M
Avg Institutional Trade (30 D):	$1.42M
Avg Institutional Trade (90 D):	$1.42M
Avg Institutional Trade Volume:	.79M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.42M
Avg Closing Trade (30 D):	$1.42M
Avg Closing Trade (90 D):	$1.42M
Avg Closing Volume:	1.38M

News

May 18, 2026 @ 12:00 PM Rein Therapeutics Announces Closing of $57.5 Milli... Source: Na

May 1, 2026 @ 12:00 AM Rein Therapeutics Announces Pricing of $50 Million... Source: Na

Feb 9, 2026 @ 6:00 PM Idiopathic Pulmonary Fibrosis Clinical Trials & Pi... Source: Delveinsight

Aug 19, 2025 @ 12:00 PM Rein Therapeutics Wins U.K. Approval to Launch Pha... Source: Rein Therapeutics

Aug 14, 2025 @ 9:00 PM Rein Therapeutics to Present Novel IPF Science and... Source: Rein Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.19	$-1.22	$-1.96
Diluted EPS	$-.19	$-1.22	$-1.96
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-5.84M	$-31.97M	$-49.87M
Operating Income / Loss	$-5.23M	$-32.66M	$-50.63M
Cost of Revenue
Net Cash Flow	$M	$.02M	$.04M
PE Ratio